Latest Share Chat

REMOVE ADS

Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

1,540.00 9.00 (0.59%)

Bid:

1,535.00

Ask:

1,536.00

Spread: 1.00 (0.065%)

Market Cap: £3.24b

Last checked at -

Intraday Hikma Pharmaceuticals Share Chart

REMOVE ADS

Hikma Pharmaceuticals News

LONDON MARKET OPEN: FTSE 100 in red; NatWest down despite profit rise

(Alliance News) - Stock prices in London opened mostly higher on Friday morning, though the FTSE 100 was hurt by poorly received results from banking ...

Hikma upgrades FY guidance, cautious on Sudan impact

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance after a stronger-than-expected start to the year for its generics business but ex...

LONDON BRIEFING: NatWest profit rises; Deutsche Bank buys Numis

(Alliance News) - Stocks in London were set to open higher on Friday, after a solid session for Asian equities and a strong finish in New York on Thur...

UK earnings, trading statements calendar - next 7 days

LONDON MARKET OPEN: Stocks looking for direction before US inflation

(Alliance News) - Stock prices in London opened mixed on Wednesday, as caution prevailed ahead of a US inflation reading and minutes from the Federal ...

Hikma Pharmaceutical appoints Injectables lead Mishlawi as new CEO

(Alliance News) - Hikma Pharmaceuticals PLC on Wednesday said it has appointed Riad Mishlawi as chief executive officer, effective September 1, allowi...

LONDON BRIEFING: Anglo American's De Beers shines; Unite bookings up

(Alliance News) - Stocks in London were called flat on Wednesday, with the focus for the day on a US inflation reading in the afternoon, before the re...

Hikma appoints Riad Mishlawi as CEO

(Sharecast News) - Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer...